Lunai Bioworks
LNAI
60 hedge funds and large institutions have $12M invested in Lunai Bioworks in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 20 reducing their positions, and 6 closing their positions.
323% more call options, than puts
Call options by funds: $55K | Put options by funds: $13K
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
7% more funds holding
Funds holding: 56 → 60 (+4)
0% less ownership
Funds ownership: 0.17% → 0.17% (-0%)
10% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 20
35% less capital invested
Capital invested by funds: $18.5M → $12M (-$6.54M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$686K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$133K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$61.6K |
| 4 |
IIM
INTECH Investment Management
West Palm Beach,
Florida
|
+$35.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
-$251K |
| 2 |
JP Morgan Chase
New York
|
-$180K |
| 3 |
Goldman Sachs
New York
|
-$146K |
| 4 |
Morgan Stanley
New York
|
-$128K |
| 5 |
Citigroup
New York
|
-$85.7K |
LNAI Hedge Fund Activity: Q1 2025 in Review
60 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q1 2025, worth a combined $12M — down 35% from $18.5M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new LNAI positions and 6 closed out — a net gain of 4 holders — while 18 added to existing stakes and 20 trimmed.
The largest buyer was BlackRock, adding an estimated $686K. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $251K sold.
- 60 institutional investors held Lunai Bioworks (LNAI) as of Q1 2025, up from 56 in Q4 2024.
- Funds reported $12M of Lunai Bioworks stock for Q1 2025, down 35% quarter-over-quarter.
- 10 funds opened new Lunai Bioworks positions in Q1 2025 and 6 closed out, a net change of +4 holders.
- The largest Lunai Bioworks buyer in Q1 2025 was BlackRock, an estimated $686K added.
- The largest Lunai Bioworks seller in Q1 2025 was Cantor Fitzgerald, an estimated $251K sold.
Based on aggregated 13F filings for Q1 2025.